SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0007 0920 OR L773:1532 1827 ;srt2:(2015-2019)"

Sökning: L773:0007 0920 OR L773:1532 1827 > (2015-2019)

  • Resultat 51-60 av 131
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
51.
  •  
52.
  • Kallio, Heini M.L., et al. (författare)
  • Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
  • 2018
  • Ingår i: British Journal of Cancer. - : Springer Science and Business Media LLC. - 0007-0920 .- 1532-1827. ; 119:3, s. 347-356
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: A significant subset of prostate cancer (PC) patients with a castration-resistant form of the disease (CRPC) show primary resistance to androgen receptor (AR)-targeting drugs developed against CRPC. As one explanation could be the expression of constitutively active androgen receptor splice variants (AR-Vs), our current objectives were to study AR-Vs and other AR aberrations to better understand the emergence of CRPC. Methods: We analysed specimens from different stages of prostate cancer by next-generation sequencing and immunohistochemistry. Results: AR mutations and copy number variations were detected only in CRPC specimens. Genomic structural rearrangements of AR were observed in 5/30 metastatic CRPC patients, but they were not associated with expression of previously known AR-Vs. The predominant AR-Vs detected were AR-V3, AR-V7 and AR-V9, with the expression levels being significantly higher in CRPC cases compared to prostatectomy samples. Out of 25 CRPC metastases that expressed any AR variant, 17 cases harboured expression of all three of these AR-Vs. AR-V7 protein expression was highly heterogeneous and higher in CRPC compared to hormone-naïve tumours. Conclusions: AR-V3, AR-V7 and AR-V9 are co-expressed in CRPC metastases highlighting the fact that inhibiting AR function via regions common to all AR-Vs is likely to provide additional benefit to patients with CRPC.
  •  
53.
  •  
54.
  •  
55.
  •  
56.
  •  
57.
  •  
58.
  •  
59.
  • Li, K., et al. (författare)
  • An epidemiologic risk prediction model for ovarian cancer in Europe : the EPIC study
  • 2015
  • Ingår i: British Journal of Cancer. - : Springer Science and Business Media LLC. - 0007-0920 .- 1532-1827. ; 112:7, s. 1257-1265
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Ovarian cancer has a high case-fatality ratio, largely due to late diagnosis. Epidemiologic risk prediction models could help identify women at increased risk who may benefit from targeted prevention measures, such as screening or chemopreventive agents. Methods: We built an ovarian cancer risk prediction model with epidemiologic risk factors from 202 206 women in the European Prospective Investigation into Cancer and Nutrition study. Results: Older age at menopause, longer duration of hormone replacement therapy, and higher body mass index were included as increasing ovarian cancer risk, whereas unilateral ovariectomy, longer duration of oral contraceptive use, and higher number of full-term pregnancies were decreasing risk. The discriminatory power (overall concordance index) of this model, as examined with five-fold cross-validation, was 0.64 (95% confidence interval (CI): 0.57, 0.70). The ratio of the expected to observed number of ovarian cancer cases occurring in the first 5 years of follow-up was 0.90 (293 out of 324, 95% CI: 0.81-1.01), in general there was no evidence for miscalibration. Conclusion: Our ovarian cancer risk model containing only epidemiological data showed modest discriminatory power for a Western European population. Future studies should consider adding informative biomarkers to possibly improve the predictive ability of the model.
  •  
60.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 51-60 av 131
Typ av publikation
tidskriftsartikel (126)
konferensbidrag (3)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (126)
övrigt vetenskapligt/konstnärligt (5)
Författare/redaktör
Weiderpass, E (9)
Glimelius, Bengt (9)
Trichopoulou, Antoni ... (5)
Holmberg, Lars (5)
Weiderpass, Elisabet ... (5)
Tjonneland, A (4)
visa fler...
Aaltonen, LA (4)
Pukkala, E (4)
Peeters, Petra H (4)
Overvad, Kim (4)
Tumino, Rosario (4)
Khaw, Kay-Tee (4)
Khaw, K. T. (4)
Tumino, R. (4)
Hall, P (4)
Hopper, JL (4)
Lubinski, J (4)
Palli, Domenico (4)
Panico, Salvatore (4)
Evans, DG (4)
Ferrari, P. (3)
Dillner, J (3)
Makitie, A (3)
Friedman, E. (3)
Mezheyeuski, Artur (3)
Brenner, H (3)
Boutron-Ruault, Mari ... (3)
Boeing, Heiner (3)
Sánchez, Maria-José (3)
Riboli, Elio (3)
Ardanaz, E. (3)
Boeing, H. (3)
Kaaks, R. (3)
Riboli, E. (3)
Lindblom, A (3)
Adami, HO (3)
Giles, GG (3)
Lundin, Eva (3)
Trichopoulos, D (3)
Lambe, Mats (3)
Kauppila, JH (3)
Travis, Ruth C (3)
Feychting, M (3)
Garmo, Hans (3)
Chang-Claude, J (3)
Easton, DF (3)
Bamia, Christina (3)
Bamia, C (3)
Lagiou, Pagona (3)
Van Hemelrijck, Miek ... (3)
visa färre...
Lärosäte
Karolinska Institutet (92)
Uppsala universitet (33)
Lunds universitet (23)
Umeå universitet (20)
Göteborgs universitet (8)
Linköpings universitet (3)
visa fler...
Kungliga Tekniska Högskolan (1)
Stockholms universitet (1)
Mälardalens universitet (1)
Jönköping University (1)
Mittuniversitetet (1)
visa färre...
Språk
Engelska (131)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (71)
Naturvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy